HUYABIO International today announced favorable Phase 1 clinical data for HBI-3000, a novel bioinspired investigational drug with promising antiarrhythmic properties, excellent tolerability and a ...

A research group led by Assistant Professor Megumi Aimoto and Professor Akira Takahara at the Faculty of Pharmaceutical Sciences, Toho University, revealed that pyrazole-3 (Pyr3), a selective ...

PHILADELPHIA (WPVI) -- Most of us have heard of atrial fibrillation, commonly called AFib. The airwaves are filled with commercials for treatments. A Roxborough woman shared her struggle with it, and ...

INDIANAPOLIS (WISH) — In the next two decades, up to 60 million people will get atrial fibrillation or A-fib. It doesn’t always show symptoms but people with it have a five-times increased risk of a ...